Vis enkel innførsel

dc.contributor.authorLi, Jinze
dc.contributor.authorRoshelli Baker, Jacqueline
dc.contributor.authorAglago, Elom K.
dc.contributor.authorZhao, Zhiwei
dc.contributor.authorJiao, Li
dc.contributor.authorFreisling, Heinz
dc.contributor.authorHughes, David J.
dc.contributor.authorEriksen, Anne Kirstine
dc.contributor.authorTjønneland, Anne
dc.contributor.authorSeveri, Gianluca
dc.contributor.authorKatzke, Verena
dc.contributor.authorKaaks, Rudolf
dc.contributor.authorSchulze, Matthias B.
dc.contributor.authorMasala, Giovanna
dc.contributor.authorPala, Valeria
dc.contributor.authorPasanisi, Fabrizio
dc.contributor.authorTumino, Rosario
dc.contributor.authorPadroni, Lisa
dc.contributor.authorVermeulen, Roel C. H.
dc.contributor.authorGram, Inger Torhild
dc.contributor.authorBraaten, Tonje Bjørndal
dc.contributor.authorJakszyn, Paula Gabriela
dc.contributor.authorSánchez, Maria-José
dc.contributor.authorGómez-Gómez, Jesús-Humberto
dc.contributor.authorMoreno-Iribas, Conchi
dc.contributor.authorAmiano, Pilar
dc.contributor.authorPapier, Keren
dc.contributor.authorWeiderpass, Elisabete
dc.contributor.authorHuybrechts, Inge
dc.contributor.authorHeath, Alicia K.
dc.contributor.authorSchalkwijk, Casper
dc.contributor.authorJenab, Mazda
dc.contributor.authorFedirko, Veronika
dc.date.accessioned2025-02-24T12:58:11Z
dc.date.available2025-02-24T12:58:11Z
dc.date.issued2024-07-26
dc.description.abstractAdvanced glycation end-products (AGEs), formed endogenously or obtained exogenously from diet, may contribute to chronic inflammation, intracellular signaling alterations, and pathogenesis of several chronic diseases including colorectal cancer (CRC). However, the role of AGEs in CRC survival is less known. The associations of pre-diagnostic circulating AGEs and their soluble receptor (sRAGE) with CRC-specific and overall mortality were estimated using multivariable-adjusted Cox proportional hazards regression among 1369 CRC cases in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Concentrations of major plasma AGEs, N<sup>ε</sup>-[carboxy-methyl]lysine (CML), N<sup>ε</sup>-[carboxy-ethyl]lysine (CEL) and N<sup>δ</sup>-[5-hydro-5-methyl-4-imidazolon-2-yl]-ornithine (MG-H1), were measured using ultra-performance liquid chromatography mass-spectrometry. sRAGE was assessed by enzyme-linked immunosorbent assay. Over a mean follow-up period of 96 months, 693 deaths occurred of which 541 were due to CRC. Individual and combined AGEs were not statistically significantly associated with CRC-specific or overall mortality. However, there was a possible interaction by sex for CEL (<i>P</i><sub>interaction</sub> = .05). Participants with higher sRAGE had a higher risk of dying from CRC (HR<sub>Q5vs.Q1</sub> = 1.67, 95% CI: 1.21–2.30, Ptrend = .02) or any cause (HR<sub>Q5vs.Q1</sub> = 1.38, 95% CI: 1.05–1.83, <i>P</i><sub>trend</sub> = .09). These associations tended to be stronger among cases with diabetes (<i>P</i><sub>interaction</sub> = .03) and pre-diabetes (<i>P</i><sub>interaction</sub> <.01) before CRC diagnosis. Pre-diagnostic AGEs were not associated with CRC-specific and overall mortality in individuals with CRC. However, a positive association was observed for sRAGE. Our findings may stimulate further research on the role of AGEs and sRAGE in survival among cancer patients with special emphasis on potential effect modifications by sex and diabetes.en_US
dc.identifier.citationLi, Roshelli Baker, Aglago, Zhao, Jiao, Freisling, Hughes, Eriksen, Tjønneland, Severi, Katzke, Kaaks, Schulze, Masala, Pala, Pasanisi, Tumino, Padroni, Vermeulen, Gram, Braaten, Jakszyn, Sánchez, Gómez-Gómez, Moreno-Iribas, Amiano, Papier, Weiderpass, Huybrechts, Heath, Schalkwijk, Jenab, Fedirko. Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients. International Journal of Cancer. 2024en_US
dc.identifier.cristinIDFRIDAID 2286075
dc.identifier.doi10.1002/ijc.35114
dc.identifier.issn0020-7136
dc.identifier.issn1097-0215
dc.identifier.urihttps://hdl.handle.net/10037/36560
dc.language.isoengen_US
dc.publisherWileyen_US
dc.relation.journalInternational Journal of Cancer
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/?/?/?/?/?/en_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2024 The Author(s)en_US
dc.titlePre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patientsen_US
dc.type.versionacceptedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel